Navigation Links
Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
Date:5/11/2012

foster manufacturer accountability
  • Conduct a communications campaign about biologics and biosimilars
  • Foster supply chain stability
  • On the first recommendation, Miletich will underscore the need for accurate tracking and tracing. "The challenge and importance of accurate tracking and tracing will increase significantly with the arrival of biosimilars in the U.S. marketplace," says Miletich. "We believe prompt identification and resolution of product problems will be facilitated by distinguishable established names.  Unlike other identifiers, established names present a risk that two or more products could share the same name, which would affirmatively confound the attribution of adverse events."

    Secondly, "The biosimilar approval pathway is a new initiative in the U.S. with many scientific and administrative challenges and nuances," Miletich says.  "It will be essential for FDA to clearly communicate to all stakeholders what biosimilar products are and are not.   For example, there should be no perception, implied or otherwise, that an FDA-approved biosimilar is somehow less effective or less safe than the reference product. However, at this time, biosimilars are not appropriate for automatic substitution – that is, without the explicit consent of the prescribing physician - unless deemed interchangeable by FDA." 

    For the third recommendation, Miletich will emphasize that FDA policy should foster supply chain stability.     

    "Recent medicine shortages have been an opportunity for some manufacturers to suggest that FDA's standards are overly rigorous and a source of the drug shortage problem.  This is exactly wrong," Miletich says. "Complex products require high standards. It is by maintaining appropriately robust good manufacturing practices and facility inspection standards that FDA assures the public the reliable supply of high quality products
    '/>"/>

    SOURCE Amgen
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Amgen to Present at the Baird Growth Stock Conference
    2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
    3. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
    4. Amgen Announces Webcast of 2012 First Quarter Financial Results
    5. UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis
    6. Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc.
    7. Schwartz Center Receives $500,000 Grant from the Amgen Foundation
    8. Amgen to Present at the Cowen and Company 32nd Annual Healthcare Conference
    9. Amgen and Micromet Announce Early Termination of HSR Waiting Period for Amgens Acquisition of Micromet
    10. Amgens Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33
    11. Amgen Announces Final Results of Its Tender Offer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/24/2014)... novembre 2014  Surgical Theater LLC ha ... esposta durante l,apertura in data 24 novembre ... la Fondazione IRCCS Istituto Neurologico Nazionale "C. ... (strumento di pianificazione chirurgica) e Surgical Navigation ... avanzata) saranno presentati in occasione dell,evento dedicato ...
    (Date:11/24/2014)... , Nov. 24, 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: ... Kim , President and CEO of Inovio Pharmaceuticals, will be ... to ring the Nasdaq Opening Bell tomorrow, Tuesday November 25, ... 15 th listing on the Nasdaq Global Select Market.  ... Kim said, "We are honored to ring the Nasdaq Opening ...
    (Date:11/23/2014)... 23, 2014  Aurobindo Pharma USA ... USP 300 mg 100-count bottles to the consumer level. ... empty capsules. Empty capsules could result in ... that could range from no effect, short term reduction ... (long period seizures) that could be life-threatening. Aurobindo Pharma ...
    Breaking Medicine Technology:La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 2La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 3La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 4Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 2Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 3Aurobindo Pharma USA, Inc. Issues Voluntary Nationwide Recall of Northstar Label Gabapentin Capsules, USP 300 mg Due to Complaints of Empty Capsules 2
    ... Academy of Ophthalmology Annual Meeting Describes ... Advance in Treatment of Endothelial Disease, NEW ... the American Academy of Ophthalmology,s Annual Meeting, Massimo Busin,MD, ... Serena,Hospital, Forli, Italy, described a technique that significantly improved,results ...
    ... NEW ORLEANS, La., Nov. 10 Ellex Medical ... design and manufacture of ophthalmic,laser and ultrasound systems, ... for non-thermal Retina Regeneration Therapy (Ellex,2RT(TM)). Results demonstrate ... and to reduce retinal edema in patients with,diabetic ...
    Cached Medicine Technology:Improved Cornea Surgery Technique Provides Enhanced Transplant Success 2Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema 2Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema 3Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema 4
    (Date:11/24/2014)... 24, 2014 Mental health issues ... They break up families, ruin careers, and generally ... for those that suffer,” says Hardy Nutritionals® ... showing that our specialized nutritional treatments can reverse ... on “Mind Over Matter”, the premiere episode of ...
    (Date:11/24/2014)... California (PRWEB) November 24, 2014 Dr. ... Diego Fertility Center, recently appeared on NBC to discuss egg ... Egg freezing has been trending in the news recently, with ... expensive procedure for women. , “[The companies] see ... who are on a career hot path.” Says Dr. Kettel. ...
    (Date:11/23/2014)... The report, “Market Snapshot: Aesthetic Lasers ... Asia-Pacific” provides quantitative analysis of the three aesthetic ... body contouring devices, non-invasive body contouring devices and ... data by revenue and volume over the 2006 ... South Korea, Australia and India. It uses data ...
    (Date:11/23/2014)... holidays can be a challenge for families of children ... an expert says. "Holidays with family can be ... have children with special needs, some care must be ... of the Sciences in Philadelphia, said in a university ... or visitors know what special requirements are needed to ...
    (Date:11/23/2014)... NY (PRWEB) November 23, 2014 More ... past month in a federal litigation involving Byetta lawsuits ... diabetes medications, Bernstein Liebhard LLP reports. , A ... claims over a class of Type 2 diabetes medications ... in the U.S. District Court, Southern District of California, ...
    Breaking Medicine News(10 mins):Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 2Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 3Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 4Health News:Holidays Can Be Sensory Overload for Kids With Autism 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4
    ... Inverness Medical Innovations, Inc. (NYSE: IMA ), a ... health at home through the merger of rapid diagnostics and ... of America and Merrill Lynch 2009 Health Care Conference being ... in New York City. Ron Zwanziger, Chief Executive Officer, ...
    ... Eclipsemed Ltd, a leading national distributor of ... Germany, a leading manufacturer of medical and aesthetic devices have ... featured on the Lifetime Network,s The Balancing Act ... and women,s issues. The program will air on Tuesday, May ...
    ... Make a Statement: Design for the Cure event representing Living ... hit reality television series "Project Runway," is participating in the ... the Cure event representing Living Positive By Design ... the event on Thursday, May 7th , Jack will ...
    ... in First Quarter ResultsHARRISBURG, Pa., May 7 ... its 2009 community outreach program has provided more ... underserved in the first quarter of 2009."The tough ... for the uninsured community to seek the proper ...
    ... and Makes Donation for Every Purchase of TENA(R) Women(TM) ... AlonePHILADELPHIA, May 7 This Mother,s Day, May 10, ... products and services under the globally-leading TENA ... up with Breast Cancer Network of Strength ...
    ... Announcing the upcoming publication of Neuromodulation , edited ... R. Rezai. , This book is the first comprehensive ... rapidly growing field of neuromodulation, by providing a complete ... applied to the brain, spinal cord, peripheral nerves, autonomic ...
    Cached Medicine News:Health News:Inverness Medical Innovations to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 12, 2009 2Health News:Body-Jet(R), State of the Art Water-Jet Assisted Liposuction Technology to be Featured on Lifetime Television Network, The Balancing Act 2Health News:'Project Runway' Designer in Chicago to Educate About Living with HIV and Combat Stigma Associated with the Disease 2Health News:'Project Runway' Designer in Chicago to Educate About Living with HIV and Combat Stigma Associated with the Disease 3Health News:'Project Runway' Designer in Chicago to Educate About Living with HIV and Combat Stigma Associated with the Disease 4Health News:United Concordia Provides $100,000 in Free Dental Services 2Health News:Breast Cancer Network of Strength(R) and SCA Personal Care North America, Through Its TENA(R) Brand, Team Up to Offer Support to Women Affected by Breast Cancer 2Health News:Breast Cancer Network of Strength(R) and SCA Personal Care North America, Through Its TENA(R) Brand, Team Up to Offer Support to Women Affected by Breast Cancer 3Health News:Breast Cancer Network of Strength(R) and SCA Personal Care North America, Through Its TENA(R) Brand, Team Up to Offer Support to Women Affected by Breast Cancer 4
    Unipolar Atrial "J" Lead...
    VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
    VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
    VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
    Medicine Products: